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ABSTRACT
Background: Oesophageal atresia (OA) is a congenital malformation that can lead
to persistent respiratory symptoms in adulthood.
Aim: To describe the prevalence of respiratory symptoms in adulthood in a popula-
tion-based study of patients with repaired OA and to compare this with the prevalence
in the general population.
Methods: Of 80 patients operated for OA in Gothenburg in 1968–1983, 79 were
located. The patients received a questionnaire on respiratory symptoms. Controls were
4979 gender- and age-matched subjects who answered the same questions.
Results: The questionnaire was answered by 73 of 79 (92%) patients. Physician-
diagnosed asthma was reported by 30% in the OA group vs 10% in the control group (OR
4.1; 95% CI 2.4–6.8), and recurrent wheeze in 29% vs 5.5% (OR 6.9; 4.1–11.6). Also
wheeze during the last year, asthma medication, a long-standing cough, cough with sputum
production and chronic bronchitis were signiﬁcantly more common among the patients
with OA. In contrast, there was no signiﬁcant difference regarding risk factors for asthma.
The prevalence of respiratory symptoms did not appear to decrease with age.
Conclusion: A high prevalence of respiratory symptoms remains among adult
patients with repaired OA. Many of the patients had an asthma diagnosis. However, asthma
heredity or allergic rhinitis was not overrepresented.
INTRODUCTION
Oesophageal atresia (OA) is a congenital malformation that
was previously fatal. In the last few decades, OA has
become a condition with a survival rate exceeding 90% (1).
The treatment is surgical reconstruction or substitution of
the oesophagus.
As a growing number of survivors are now reaching adult-
hood, there is considerable interest in the long-term out-
come in terms of morbidity and quality of life (QoL). We
know that respiratory symptoms, dysphagia and gastro-
oesophageal reﬂux (GER) are overrepresented when the
subjects reach adulthood (2,3).
There are many factors that could contribute to the respi-
ratory symptoms after the repair of OA. A possible associa-
tion between GER and asthma is well known (4). Among
patients with OA, abnormal airway epithelium and tracheo-
malacia could also contribute to the symptoms (1,2).
Although it has been reported that the respiratory symp-
toms become less frequent with time (2), the problems con-
tinue into adulthood in many subjects (5). However, there is
still a shortage of population-based studies in which the
respiratory symptoms during adulthood are compared with
the prevalence in the general population. There is therefore
a need for more information on the long-term outcome in
this patient group.
The aim of this population-based study was to describe
the occurrence of respiratory symptoms in adulthood
among patients undergoing surgery for OA, compared with
the presence of the symptoms in the general population.
MATERIAL AND METHODS
Patients
Between 1968 and 1983, 110 consecutive patients with OA
were identiﬁed and treated at the Children’s Hospital in
Gothenburg. The patients and their characteristics have
previously been described by Sille ´n et al. (6).
Key notes
• A high prevalence of respiratory symptoms including
asthma-like symptoms, wheeze and cough remains in
adulthood in patients with repaired oesophageal atresia.
• Many of the oesophageal atresia patients had an asthma
diagnosis. However, the high prevalence of allergic rhini-
tis and a family history of asthma, usually seen in asthma,
were not seen.
• In this study, the prevalence of respiratory symptoms did
not appear to decrease with age.
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children born with OA within this area are referred to the
Department of Paediatric Surgery at the Children’s Hospital
in Gothenburg. The study is therefore population based.
The region has 1.5 million inhabitants, one-sixth of the pop-
ulation of Sweden. The largest city in the region is Gothen-
burg, with 500 000 inhabitants.
Of 80 survivors, 79 (42 men and 37 women) were located
through the Swedish Population Register. Their hospital
records were reviewed for clinical data.
Of the 79 patients, 69 (87%) had OA with a distal tracheo-
oesophageal ﬁstula (TOF), three had OA without a TOF
(pure OA), ﬁve had a TOF without any OA, one had OA
with a proximal ﬁstula and one had OA with double TOFs
(7).
Associated malformations were present in 28 (35%) of
the patients (Table 1). A diagnosis of VACTERL (vertebral,
anorectal, cardiac, tracheo-oesophageal, renal and limb)
association (deﬁned as the presence of three or more com-
ponents) was made in seven patients (9%).
Questionnaires
In the spring of 2008, the located 79 patients were con-
tacted with a letter describing the study. The patients were
asked whether they were willing to participate. If no answer
was received, the patients were reminded by telephone and
by letter. The patients were offered to make contact by tele-
phone if they had any questions about the study. The study
is part of a larger investigation of the long-term outcome in
adults with repaired OA. Results regarding their QoL and
symptoms of dysphagia have been reported in a previous
article (7).
The patients that agreed to participate received a ques-
tionnaire with 33 questions based on the Swedish OLIN
(Obstruktiv Lungsjukdom i Norrbotten, Obstructive Lung
Disease in Northern Sweden) questionnaire (8). The OLIN
questions have been used in several studies of obstructive
lung disease in Northern Europe. The questionnaire con-
tained questions on obstructive respiratory disease, respira-
tory symptoms, rhinitis and possible risk factors for disease,
such as smoking and a family history of asthma or allergy.
The patients were also asked about medication, weight,
height and possible other diseases.
As controls, 4979 gender- and age-matched subjects
from the same geographical region were used. These
subjects were obtained from the West Sweden Asthma
Study where data collection was also performed in 2008
(9). The West Sweden Asthma Study also uses questions
from the OLIN study. As a result, the questions in the OA
questionnaire were the same as in the West Sweden
Asthma Study from which appropriate data were
extracted. To make our study comparable to previous stud-
ies on respiratory symptoms in patients with repaired OA,
we focused on 12 questions related to respiratory symp-
toms, allergy and smoking.
Questions
Physician-diagnosed asthma: ‘Have you been diagnosed as
having asthma by a doctor’? Asthma medication: ‘Do you
currently use asthma medicine (permanently or as
needed)’?
Wheezing last 12 months: ‘Have you had whistling or
wheezing in the chest on any occasion during the last
12 months’?
Recurrent wheeze: ‘Do you usually have wheezing or
whistling in your chest when you breathe’?
Long-standing cough: ‘Have you had a persistent cough
during the last few years’?
Cough with sputum production: ‘Do you usually produce
phlegm when you cough or do you have phlegm in your
chest which is difﬁcult to bring up’?
Chronic bronchitis: ‘Have you ever had a cough with
phlegm for 3 months or more a year for at least 2 years’?
Allergic rhinitis: ‘Have you ever had allergic eye or nose
problems (hay fever)’?
Family history of asthma: ‘Has any of your parents or sib-
lings ever had asthma’?
Family history of allergic rhinitis: ‘Has any of your par-
ents or siblings ever had allergic eye or nose problems (hay
fever)’?
Family history of chronic bronchitis or emphysema: ‘Has
any of your parents or siblings ever had chronic bronchitis
or emphysema’?
Smokers reported smoking during the year preceding the
survey. Ex-smokers reported having stopped smoking at
least 12 months prior to the survey.
Statistical methods
For comparisons between the two groups, Fisher’s exact test
was used for dichotomous variables. Odds ratios (OR) with
95% conﬁdence intervals (CI) were calculated from 2 · 2
contingency tables using standard methods.
Ethical approval
The study was approved by the ethics committee at the Uni-
versity of Gothenburg.
RESULTS
Of the 79 patients, 73 (92%) completed the questionnaire.
The mean age was 31.7 years for the participants (median
31; range 25–40) and 32.6 years for the controls (33; 25–
40). The mean weight and height of the women with
Table 1 Associated malformations in the patients with oesophageal atresia (n = 79)
Associated malformations Number of patients (%)
Gastrointestinal 9 (11.4)
Musculoskeletal 9 (11.4)
Congenital heart disease 7 (8.9)
Urogenital 5 (6.3)
Face 3 (3.8)
CNS 2 (2.5)
Chromosomal aberration 1 (1.3)
CNS = central nervous system.
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158–173), and for men it was 77.5 kg (58–120) and 178 cm
(164-190). The mean body mass index (BMI) for the group
with repaired OA was 24 (range 17.6–50.8). Three patients
did not provide complete information on their weight, and
one patient did not mention his height.
Concomitant diagnoses
Three patients reported having a psychiatric diagnosis. Two
patients had an inﬂammatory bowel disease. One patient,
born with a ventricular septum defect, had a pacemaker.
One patient had hepatitis and one reported having gout.
Respiratory symptoms
The prevalence of respiratory symptoms is presented in
Table 2. Respiratory symptoms were consistently more
common among patients with OA than controls. Physician-
diagnosed asthma was reported by 30% in the OA group vs
10% in the control group (p < 0.001). Asthma medication
was used by 24% of the patients with repaired OA vs 9%
of the controls (p < 0.001). However, only 7% in the OA
group used asthma medication on a regular basis. These
ﬁve patients all used combination therapy with an inhaled
corticosteroid plus a long-acting bronchodilator.
Also wheeze during the last year, recurrent wheeze, a
long-standing cough, cough with sputum production and
chronic bronchitis were signiﬁcantly more common among
the patients with repaired OA than among the controls.
The OR for physician-diagnosed asthma among the
patients with repaired OA compared with the control group
was 4.1. Similarly, the OR for using asthma medication was
3.3, while the OR for recurrent wheeze was 6.9.
In contrast, there was no statistically signiﬁcant difference
between the OA and control group regarding reported aller-
gic rhinitis (current orprevious), 41% vs 32% (p = 0.16).
Heredity and smoking
There was no statistically signiﬁcant difference in terms of a
family history (parents or siblings) of asthma, allergic rhini-
tis or chronic bronchitis between the patients with repaired
OA and the controls. Nor was there any statistically signiﬁ-
cant difference in the prevalence of smokers or ex-smokers
between the groups (Table 3).
DISCUSSION
The main ﬁnding in this study is the high prevalence of
respiratory symptoms in adulthood in the OA group com-
pared with the controls, including a diagnosis of asthma
and the use of asthma medication.
To our knowledge, there is only one previous population-
based study of operated OA followed to adulthood, and our
results of a high rate of respiratory morbidity in the OA
group are in agreement with the results of this recent Finn-
ish study (5).
Wheezing is one of the main respiratory symptoms fol-
lowing repaired oesophageal atresia (1,2). This was clearly
seen in the present follow-up where the prevalence of
wheeze and asthma diagnosis (44% and 30%) was even
higher than in the Sistonen study (37% and 16%) (5).
In the Sistonen study, the occurrence of respiratory symp-
toms among the adult patients with repaired OA was lower
than what has been reported for children and adolescents
with OA (5), suggesting an improvement with age (2,10).
Regrettably, we do not have data on the previous prevalence
of respiratory symptoms in our OA cohort. However, when
compared with studies performed in childhood or adoles-
cence (11), our follow-up data do not indicate a reduced
prevalence with age. Chetcuti and Phelan reported that the
prevalence of a persistent cough declined from 32% in
patients at preschool age to 9% among patients over
15 years (2). This can be compared with our high preva-
lence of a long-standing cough. However, the possibility
exists that the severity had decreased, despite a high per-
centage reporting still having symptoms.
The prevalence of asthma among patients with OA varies
between 12% and 29% in different studies (5,10–15). One
question is whether the diagnostic term ‘asthma’ is correctly
used in this patient group. This question cannot be
answered in a questionnaire-based study, but some observa-
tions may be of interest in this context. Even though physi-
cian-diagnosed asthma was signiﬁcantly higher in the OA
group, there was no over-representation of rhinitis or a fam-
ily history of asthma which usually is the case in subjects
with asthma (9). This could lend support to a speculation
that some of the patients with OA have asthma-like symp-
toms rather than asthma, a speculation supported by obser-
vations in other studies. For example, Agrawal et al. (14)
examined the effect of bronchodilators in 12 children with
Table 2 Prevalence of various respiratory symptoms in patients with repaired
oesophageal atresia and controls
Variable OA, n (%) Controls, n (%) OR (95% CI)
Physician-diagnosed asthma 22 (30.1) 477 (9.6) 4.1 (2.4–6.8)
Asthma medication 17 (23.9) 432 (8.7) 3.3 (1.9–5.8)
Wheezing last 12 months 32 (44.4) 825 (16.6) 4.0 (2.5–6.4)
Recurrent wheeze 21 (28.8) 275 (5.5) 6.9 (4.1–11.6)
Long-standing cough 22 (30.1) 573 (11.5) 3.3 (2.0–5.5)
Cough with sputum
production
25 (34.2) 633 (12.7) 3.6 (2.2–5.8)
Chronic bronchitis 10 (13.7) 321 (6.4) 2.3 (1.2–4.5)
OA = oesophageal atresia, OR = odds ratio, 95% CI = 95% conﬁdence
interval.
Table 3 Prevalence of heredity and smoking in patients with repaired oesophageal
atresia and controls
Variable OA, n (%) Controls, n (%) p-value
Family history of asthma 18 (25.4) 943 (19.6) 0.2902
Family history of allergic rhinitis 23 (32.9) 1874 (38.8) 0.3762
Family history of chronic
bronchitis or emphysema
4 (5.7) 275 (5.8) 1.000
Smoker 14 (19.2) 677 (14.0) 0.2720
Ex-smoker (stopped >1 year ago) 15 (25.9) 810 (18.9) 0.2422
OA = oesophageal atresia.
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only one responded to salbutamol. In adolescents with
repaired OA, Malmstro ¨m et al. (11) did not ﬁnd any signiﬁ-
cant association between bronchial responsiveness to hista-
mine and doctor-diagnosed asthma. Nor did bronchial
biopsies demonstrate histological ﬁndings typical of asthma.
Furthermore, there was no signiﬁcant correlation between
exhaled nitric oxide (NO) levels, which are expected to
increase in eosinophil airway inﬂammation, and the respira-
tory symptoms of patients with OA. Normally, asthma is
associated with bronchial hyper-responsiveness (16), but
although many patients with repaired OA have bronchial
hyper-responsiveness (17), few studies have demonstrated a
correlation with current respiratory symptoms (5). Other
studies have failed to ﬁnd a signiﬁcant correlation between
the respiratory symptoms in patients with OA and a positive
airway challenge (12,18).
Taken together, this suggests that caution should be
advised when deciding whether an OA patient with asthma-
like symptoms actually has asthma.
The signiﬁcant increase in the risk of a long-standing
cough and a cough with sputum production among the OA
subjects could not be explained by smoking because there
was no statistical difference in smoking prevalence between
the OA group and the controls.
The majority of the patients underwent surgery for the
most common type of OA, that is, OA with a distal TOF.
The other four types of OA represented only small numbers
(7), and for this reason, we did not feel that it was reliable to
analyse whether or not the respiratory symptoms were cor-
related with the type of atresia.
The weaknesses of this study are those inherent to all
questionnaire-based studies regarding the validity of
answers. Another weakness is the fact that we do not have
lung function measurements of the study subjects. Such
measurements are planned in the next phase of this study.
The strengths of the study are that it is population based
and that it has a high response rate, over 90%. Another
strength is that the comparisons were made with a large
control group that is representative of the general popula-
tion (19).
CONCLUSION
To summarize, the high prevalence of respiratory symptoms
remains in adulthood in patients with repaired OA. Many of
the patients have asthma-like symptoms and an asthma
diagnosis. However, the high prevalence of allergic rhinitis
and a family history of asthma that is usually seen in asthma
were not seen in the OA group.
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